Cardiome Announces CEO Doug Janzen Has Left Company

Loading...
Loading...
Cardiome Pharma Corp.
CRME
today announced that CEO Doug Janzen has left the Company. Dr. William Hunter, a member of the Company's board of directors, has been appointed interim CEO.
Posted In: NewsManagement
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...